Onderneming Medivir AB (publ) OTC Markets
Aandelen
MVRBF
SE0020181014
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 10
Verkoop per activiteit
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 4 | 100,0 % | 8 | 100,0 % | +73,16% |
Verkoop per regio
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
46,9
%
| - | - | 4 | 46,9 % | - |
Europe, Other
43,3
%
| 4 | 80,8 % | 3 | 43,3 % | -7,16% |
Rest of the World
4,8
%
| 0 | 9,9 % | 0 | 4,8 % | -16,21% |
Sweden
2,5
%
| 0 | 5,0 % | 0 | 2,5 % | -13,12% |
Nordic Region, Other
2,4
%
| 0 | 4,2 % | 0 | 2,4 % | -0,53% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jens Lindberg
CEO | Chief Executive Officer | 53 | 24-01-22 |
Director of Finance/CFO | 50 | 12-08-19 | |
Uli Alf Hacksell
CHM | Chairman | 74 | 03-05-18 |
Pia Baumann
CTO | Chief Tech/Sci/R&D Officer | 58 | 20-02-23 |
Malene Jensen
CTO | Chief Tech/Sci/R&D Officer | 54 | 01-10-21 |
Fredrik Öberg
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-01-11 |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 26-05-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 03-05-18 |
Director/Board Member | 68 | 03-05-18 | |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 26-05-20 |
Bengt Westermark
BRD | Director/Board Member | 79 | 03-05-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 864 750 | 0 | 864 750 ( 100,00 %) | 64,10 % |
Aandeel B | 1 | 112 053 218 | 72 375 356 ( 64,59 %) | 11 413 ( 0,0102 %) |
Bedrijfsgegevens
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,63% | 114 mld. | |
+13,17% | 107 mld. | |
-12,76% | 22,22 mld. | |
-3,99% | 21,28 mld. | |
-7,19% | 17,51 mld. | |
-39,93% | 17,17 mld. | |
+6,67% | 14,14 mld. | |
+33,90% | 12,2 mld. | |
-28,60% | 7,83 mld. |